Putting a hex on leukaemia
18 January, 2016Scientists have discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models and could also be a key target for new therapies for human leukaemia.
Imugene patent granted in Europe
18 December, 2015Imugene has received a Notice of Grant from the European Patent Office for Patent Application 10744895.3, which protects the company's HER-Vaxx cancer immunotherapy.
NFMRI announces 2016 grant recipients
04 December, 2015The National Foundation for Medical Research and Innovation has announced its 2016 grant recipients, supporting researchers from across the country in the advancement of their medical innovations.
Could we kill two diseases with one campaign?
04 December, 2015 by Graeme O'NeillBritish researchers have proposed that the WHO's planned mass treatment campaign to eradicate the tropical disease yaws from the planet by 2020 should be integrated with a WHO-led project to eliminate another common disease of the world's poor — trachoma — with the same deadline.
Identifying Alzheimer's genes
02 December, 2015In a study led by The Australian National University, scientists have identified a network of nine genes that play a key role in the onset of Alzheimer's disease.
$3 million to fight rare cancers
26 November, 2015The Stafford Fox Medical Research Foundation will support the Walter and Eliza Hall Institute in its development of new strategies for diagnosing and treating patients with rare cancers.
ANU to host cognitive health research centre
25 November, 2015ANU has been awarded $2.5 million in the latest NHMRC funding round to host a new Centre of Research Excellence on Cognitive Health.
$9 million to treat heart failure and peanut allergies
23 November, 2015Medical technology companies Cardiora and Aravax have been awarded $9 million in venture capital funding from the Medical Research Commercialisation Fund to develop novel treatments for heart failure and peanut allergies respectively.
Mutant MYC inhibited by Phylogica
16 November, 2015Phylogica has announced the inhibition of the mutant gene MYC — which many cancers depend on for their survival — in an animal model.
Australia's biggest ageing study just got better
13 November, 2015Enhancements to the Sax Institute's 45 and Up Study will help drive research into the genetic causes of various diseases, as well as to build predictive models on the risk of disease.
Lupus: in search of the wolf
12 November, 2015 by Graeme O’NeillA three-year-old patient, and a crucial discovery by Professor Carola Vinuesa's ANU research team, will transform diagnosis and treatment of lupus.
Balnaves Foundation funds two more child cancer researchers
12 November, 2015The Balnaves Foundation has awarded two Children's Cancer Institute Australia researchers $100,000 each to explore uncharted territory in childhood cancer.
Blocking neuroblastoma
09 November, 2015Scientists have identified a critical molecular 'feedback loop' that helps initiate and drive neuroblastoma — as well as a drug that has the potential to stop it.
Viralytics and MSD collaborate on combination cancer trial
06 November, 2015A new clinical trial will evaluate the combination of Viralytics' investigational cancer immunotherapy, CAVATAK, with MSD's KEYTRUDA, an anti-PD-1 (programmed death receptor-1) therapy.
Accelerating the search for an HIV vaccine
06 November, 2015The European AIDS Vaccine Initiative (EAVI2020) is a €23 million program to speed up the search for an effective HIV vaccine.
